Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Conavi Medical Corp T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Comment by Pandoraon Oct 08, 2024 5:39pm
69 Views
Post# 36258518

RE:TMD Titan Medical merger with Conavi is great news for share

RE:TMD Titan Medical merger with Conavi is great news for share
A 25 for 1 consolidation suggests a price around $1.25 to $1.50 based on a current 5 cents, maybe 6 cents. The name will change to Conavi and the transaction is expected to close on October 11, 2024 (Friday) so it should open on Monday under the new name and price.

What are the views for the new company? Growth from the get go or a slide backwards? Consolidations never seem to have a positive tilt.
<< Previous
Bullboard Posts